THE 12Q13-Q15 TRANSLOCATION BREAKPOINTS IN PLEOMORPHIC ADENOMA AND CLEAR-CELL SARCOMA OF TENDONS AND APONEUROSES ARE DIFFERENT FROM THAT INMYXOID LIPOSARCOMA

Citation
G. Stenman et al., THE 12Q13-Q15 TRANSLOCATION BREAKPOINTS IN PLEOMORPHIC ADENOMA AND CLEAR-CELL SARCOMA OF TENDONS AND APONEUROSES ARE DIFFERENT FROM THAT INMYXOID LIPOSARCOMA, Genes, chromosomes & cancer, 7(3), 1993, pp. 178-180
Citations number
15
Categorie Soggetti
Oncology,"Genetics & Heredity
Journal title
ISSN journal
10452257
Volume
7
Issue
3
Year of publication
1993
Pages
178 - 180
Database
ISI
SICI code
1045-2257(1993)7:3<178:T1TBIP>2.0.ZU;2-3
Abstract
The transcription factor gene CHOP was recently shown to be rearranged in myxoid liposarcoma with t(I 2; 1 6)(q13;p11). We have analyzed whe ther the CHOP gene is the target of rearrangements in pleomorphic aden oma and clear-cell sarcoma of tendons and aponeuroses with chromosome abnormalities of 12q13-q15. Restriction fragment analysis showed that the CHOP gene and its flanking sequences were not rearranged in any of these tumor types, indicating that the 12q translocation breakpoints in pleomorphic adenoma and clear-cell sarcoma are different from that in myxoid liposarcoma. (C) 1993 Wiley-Liss, Inc.